BYDUREON Trademark

Trademark Overview

On Thursday, November 15, 2007, a trademark application was filed for BYDUREON with the United States Patent and Trademark Office. The USPTO has given the BYDUREON trademark a serial number of 77331009. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2011. This trademark is owned by Amylin Pharmaceuticals, Inc. The BYDUREON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications and hormonal diseases and disorders
bydureon

General Information

Serial Number77331009
Word MarkBYDUREON
Filing DateThursday, November 15, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications and hormonal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmylin Pharmaceuticals, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, June 27, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 27, 2011ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 11, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2010EXTENSION 5 GRANTED
Tuesday, November 9, 2010EXTENSION 5 FILED
Tuesday, November 9, 2010TEAS EXTENSION RECEIVED
Thursday, April 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2010EXTENSION 4 GRANTED
Tuesday, April 20, 2010EXTENSION 4 FILED
Tuesday, April 20, 2010TEAS EXTENSION RECEIVED
Friday, November 6, 2009EXTENSION 3 GRANTED
Thursday, November 5, 2009EXTENSION 3 FILED
Thursday, November 5, 2009TEAS EXTENSION RECEIVED
Friday, April 17, 2009EXTENSION 2 GRANTED
Monday, April 6, 2009EXTENSION 2 FILED
Friday, April 17, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 6, 2009TEAS EXTENSION RECEIVED
Thursday, February 26, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 26, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 13, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 13, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 28, 2008EXTENSION 1 GRANTED
Tuesday, October 28, 2008EXTENSION 1 FILED
Tuesday, October 28, 2008TEAS EXTENSION RECEIVED
Tuesday, May 27, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 4, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2008NOTICE OF PUBLICATION
Wednesday, January 30, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 29, 2008ASSIGNED TO LIE
Monday, December 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 16, 2007ASSIGNED TO EXAMINER
Wednesday, November 21, 2007NOTICE OF PSEUDO MARK MAILED
Tuesday, November 20, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

bydureon disorders pharmaceutical preparations diabetic complications diseases hormonal diabetes endocrine namely